Sofiva Genomics Co.,Ltd. (6615.TWO)

TWD 32.65

(-4.81%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 466.79 Million 495.77 Million 508.41 Million 488.86 Million 509.44 Million
Cost of Revenue 336.88 Million 346.78 Million 331.6 Million 336.12 Million 311.46 Million
Gross Profit 129.9 Million 148.98 Million 176.81 Million 152.74 Million 197.98 Million
Operating Expenses 145.79 Million 145.68 Million 141.71 Million 132.16 Million 131.26 Million
Selling, General and Administrative Expenses 136.15 Million 135.35 Million 130.91 Million 122.54 Million 123.32 Million
Research and Development Expenses 9.63 Million 10.33 Million 10.79 Million 9.62 Million 7.93 Million
Other Expenses - 2.47 Million -1.2 Million 413 Thousand -
Cost and Expenses 482.67 Million 492.47 Million 473.31 Million 468.29 Million 442.72 Million
Operating Income -15.88 Million 48.35 Million 65.29 Million 38.89 Million 66.72 Million
Interest Expense 1.28 Million 1.48 Million 1.73 Million 1.96 Million 1.96 Million
Income Tax Expense -3.02 Million 4.19 Million 6.92 Million 3.07 Million 12.93 Million
Earnings before Tax 8.9 Million 47.34 Million 63.69 Million 37.27 Million 65.81 Million
Net Income 11.52 Million 42.77 Million 56.97 Million 34.62 Million 62.67 Million
Earnings Per Share Basic 0.54 2.00 2.68 1.63 2.96
Earnings Per Share Diluted 0.54 2.00 2.68 1.62 2.92
Weighted Average Shares Outstanding 21.36 Million 21.36 Million 21.28 Million 21.22 Million 21.17 Million
Weighted Average Shares Outstanding (Diluted) 21.36 Million 21.37 Million 21.29 Million 21.38 Million 21.45 Million
Gross Margin 0.28 0.30 0.35 0.31 0.39
EBIT Margin 0.06 0.18 0.21 0.18 0.21
Profit Margin 0.02 0.09 0.11 0.07 0.12
EBITDA 27.86 Million 91.14 Million 107.24 Million 87.06 Million 108.62 Million
Earnings Before Tax Margin -0.03 0.10 0.13 0.08 0.13

Income Statement Charts